Clearwater Analytics Goes Private in $8.4B Deal, 47% Premium for Shareholders

TL;DR

**CWAN shareholders are cashing out big with a 47% premium, making this a no-brainer exit for a company looking to innovate away from public market scrutiny.**

AI Summary

Clearwater Analytics Holdings, Inc. (CWAN) has entered into a definitive agreement to be acquired by a private equity consortium including Permira, Warburg Pincus, Francisco Partners, and Temasek for approximately $8.4 billion. Stockholders will receive $24.55 per share in cash, representing a substantial 47% premium over the undisturbed share price of $16.69 as of November 10, 2025. The transaction is expected to close in the first half of 2026, pending regulatory and stockholder approvals. This move aims to provide greater flexibility for long-term investments, strategic acquisitions like Beacon and Enfusion, and accelerated product innovation, including Gen AI capabilities, by reducing public market pressures. Existing equity awards for employees will generally convert to cash at $24.55 per share upon vesting, with unvested PSUs achieving maximum 110% performance. The company plans to continue business as usual, with no immediate changes to hiring, layoffs, or leadership, except for the Board of Directors.

Why It Matters

This acquisition offers a significant 47% premium to Clearwater Analytics shareholders, providing a clear exit at a high valuation. For employees, while the leadership team remains stable, the shift to private ownership could mean a longer-term strategic focus, potentially fostering innovation in areas like Gen AI without quarterly public market pressures. In the competitive financial software landscape, this move allows CWAN to integrate recent acquisitions like Beacon and Enfusion more effectively and invest more aggressively in its front-to-back platform vision, potentially strengthening its market position against rivals by accelerating product development and expanding into new markets like APAC with Temasek's support.

Risk Assessment

Risk Level: medium — The risk level is medium due to the inherent uncertainties of a pending acquisition. The filing explicitly states the transaction is "subject to customary closing conditions, including receipt of regulatory approvals and a vote by CWAN stockholders," and warns of risks like "failure to receive... required approvals" and "the occurrence of any event... that could give rise to the termination of the definitive transaction agreement." While the premium is attractive, the deal is not yet final.

Analyst Insight

Investors should hold their CWAN shares to realize the $24.55 per share cash payout upon closing, assuming the deal proceeds as expected. New investors should consider the limited upside given the fixed acquisition price and the remaining regulatory and shareholder approval risks.

Key Numbers

• $8.4B — acquisition valuation (total value of the transaction for Clearwater Analytics)
• $24.55 — per-share purchase price (cash amount stockholders will receive for each share)
• 47% — premium over undisturbed share price (increase from CWAN's $16.69 share price on November 10, 2025)
• $16.69 — undisturbed share price (CWAN's closing price on November 10, 2025, prior to media reports)
• 110% — maximum PSU achievement level (performance condition for unvested PSUs will be deemed achieved at this level)
• 2026 — expected closing year (transaction is expected to close in the first half of 2026)

Key Players & Entities

• Clearwater Analytics Holdings, Inc. (company) — target of acquisition
• Permira (company) — acquiring private equity investor
• Warburg Pincus (company) — acquiring private equity investor
• Francisco Partners (company) — new acquiring private equity investor
• Temasek (company) — new acquiring private equity investor
• Sandeep Sahai (person) — CEO of Clearwater Analytics
• Andy Young (person) — Board member from Permira
• Cary Davis (person) — Board member from Warburg Pincus
• New York Stock Exchange (regulator) — exchange where CWAN shares currently trade
• SEC (regulator) — regulator for public companies

FAQ

Risk Factors

• Regulatory Approvals for Acquisition [medium — regulatory]: The acquisition by a private equity consortium is contingent upon receiving customary closing conditions, including regulatory approvals. Failure to obtain these approvals could prevent the transaction from closing, leaving Clearwater Analytics as a public company.
• Shareholder Approval for Acquisition [medium — market]: The definitive agreement requires approval from Clearwater Analytics stockholders. A negative vote could block the $8.4 billion acquisition, impacting the planned transition to private ownership and the $24.55 per share cash payout.
• Integration of Acquired Companies [medium — operational]: The company plans to integrate strategic acquisitions like Beacon and Enfusion, and accelerate product innovation, including Gen AI capabilities. Successful integration is crucial for realizing the long-term benefits of these investments and the private equity ownership.
• Employee Retention and Morale [medium — operational]: While the company states no immediate changes to hiring or layoffs, the transition to private ownership and the conversion of equity awards to cash could impact employee morale and retention, particularly for key talent. The maximum 110% PSU achievement level aims to mitigate some of this impact.
• Post-Acquisition Investment Strategy [medium — financial]: As a private entity, Clearwater Analytics will have greater flexibility for long-term investments. The success of this strategy hinges on the private equity consortium's ability to deploy capital effectively and achieve projected growth without public market pressures.
• ESPP and Option Handling [low — legal]: The Employee Stock Purchase Plan (ESPP) and stock options have specific handling procedures depending on the closing date relative to offering periods and strike prices. Any miscommunication or unfavorable outcomes for participants could lead to disputes.

Industry Context

The financial technology (fintech) sector, particularly in investment management solutions, is characterized by increasing demand for integrated platforms and advanced analytics. Companies are investing heavily in areas like AI and cloud-based services to enhance efficiency and client offerings. Clearwater Analytics operates in a competitive landscape with players offering specialized or broader solutions, making strategic acquisitions and product innovation crucial for market positioning.

Regulatory Implications

The acquisition requires regulatory approvals, which could introduce delays or conditions. Post-transaction, Clearwater Analytics will no longer be subject to public company reporting requirements, reducing its SEC compliance burden but also limiting public scrutiny. The shift to private ownership may allow for more strategic, long-term investments without immediate public market pressures.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-11-10: Undisturbed Share Price Date — This date marks the closing price of $16.69 before media reports of a potential transaction, establishing the baseline for the acquisition premium.
• 2025-12-21: Employee Town Hall and FAQ Distribution — The company communicated the acquisition details and addressed employee concerns via an email and an FAQ, outlining the impact on compensation and operations.
• 2026-01: Leadership Q&A Sessions — Leadership planned to conduct live Q&A sessions with employees to further address questions and concerns regarding the acquisition.
• 2026-05-31: Potential ESPP Offering Period End — This date is a potential end date for the current ESPP offering period, with specific rules dictating how it will be handled if the acquisition closes before or after this date.
• 2026-H1: Expected Transaction Closing — The acquisition by the private equity consortium is anticipated to be completed in the first half of 2026, subject to regulatory and shareholder approvals.
• 2026-01-01: Planned Equity Grant for Enfusion Employees — A planned equity grant for identified individuals from Enfusion was scheduled to proceed on this date, indicating continued investment in key personnel despite the acquisition.

Glossary

Definitive Agreement

A legally binding contract that outlines the terms and conditions of a transaction, such as an acquisition. (This document signifies that Clearwater Analytics has formally agreed to be acquired by the private equity consortium.)

Private Equity Consortium

A group of private equity firms that pool their resources to make a significant investment or acquisition. (Identifies the collective buyers (Permira, Warburg Pincus, Francisco Partners, and Temasek) in the $8.4 billion acquisition of Clearwater Analytics.)

Undisturbed Share Price

The stock price of a company on a specific date before any significant news or events that could influence its valuation, such as rumors of a merger or acquisition. (Used to calculate the premium offered in the acquisition, showing the increase from $16.69 on November 10, 2025, to the $24.55 per share offer.)

RSUs (Restricted Stock Units)

A form of employee compensation that grants the recipient shares of stock after a vesting period or upon meeting certain conditions. (Vested RSUs will be settled in cash at $24.55 per share, while unvested RSUs will continue to vest on their original schedule but be paid in cash.)

PSUs (Performance Stock Units)

Stock units that vest only if specific performance goals are met within a defined timeframe. (Unvested PSUs will vest based on time-based conditions, with the performance condition deemed achieved at the maximum 110% level, and will be settled in cash.)

Gen AI

Generative Artificial Intelligence, a type of AI that can create new content, such as text, images, or code. (The company plans to accelerate product innovation, including Gen AI capabilities, as a private entity, indicating a strategic focus on this technology.)

Going Private

The process by which a publicly traded company becomes privately owned, typically by being acquired by a private equity firm or management buyout. (Clearwater Analytics will no longer trade on the NYSE and will be exempt from SEC reporting requirements after the transaction closes.)

ESPP (Employee Stock Purchase Plan)

A plan that allows employees to purchase company stock, often at a discount, through payroll deductions. (The FAQ outlines specific rules for how the ESPP will be handled depending on the transaction's closing date relative to the offering period.)

Year-Over-Year Comparison

This filing is a proxy statement related to a definitive agreement for acquisition, not a typical annual report. Therefore, direct year-over-year financial metric comparisons (revenue growth, margin changes) are not applicable. The primary focus is on the transaction details, including the acquisition valuation of $8.4 billion and the $24.55 per share offer price, representing a 47% premium. New risks highlighted relate to the closing conditions of the acquisition, such as regulatory and shareholder approvals, and the operational implications of transitioning to private ownership.

Key Financial Figures

• $8.4 billion — hat values the company at approximately $8.4 billion. b. Under the terms of the agreement,
• $24.55 — reement, CWAN stockholders will receive $24.55 per share in cash upon completion of th
• $16.69 — over CWAN's undisturbed share price of $16.69 as of November 10, 2025, the last tradi
• $24 — .55. If the strike price is at or above $24.55, then those options will be cancelle

Filing Documents

• cwan-20251222.htm (DEF 14A) — 305KB
• 0001866368-25-000037.txt ( ) — 440KB
• cwan-20251222.xsd (EX-101.SCH) — 1KB
• cwan-20251222_htm.xml (XML) — 1KB

From the Filing

cwan-20251222 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 _______________ Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials x Soliciting Material under 240.14a-12 Clearwater Analytics Holdings, Inc. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): x No fee required o Fee paid previously with preliminary materials o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 The following email was sent to employees of Clearwater Analytics Holdings, Inc. on December 21, 2025: Team - Thank you for taking the time to attend the town hall - I know it ran over meaningfully, but we wanted to answer as many questions as we could. Here is the FAQ I referred to during the Townhall. It contains details about some of the answers we provided. Please reach out to Cindy or her team, if you have any questions. Members of the ELT and I will try and get to as many offices as we can in January to do live Q&A sessions and answer any questions you may have. This is an exciting opportunity for us to emerge as an industry powerhouse, and I look forward to working with all you in the days and years ahead. Best, Sandeep Below is the attachment referred to in the email: Employee FAQ December 22, 2025 OVERVIEW 1. What is being announced? a. Clearwater Analytics (CWAN) has entered into a definitive agreement to be acquired by a consortium of private equity investors, including Permira, Warburg Pincus, Francisco Partners, and Temasek, in a transaction that values the company at approximately $8.4 billion. b. Under the terms of the agreement, CWAN stockholders will receive $24.55 per share in cash upon completion of the proposed transaction. The per-share purchase price represents a premium of 47% over CWAN's undisturbed share price of $16.69 as of November 10, 2025, the last trading day prior to media reports regarding a potential transaction. c. The transaction is expected to close in the first half of 2026, subject to customary closing conditions, including receipt of regulatory approvals and a vote by CWAN stockholders. 2. Who is acquiring CWAN? a. CWAN is being acquired by Permira, Warburg Pincus, Francisco Partners, and Temasek. b. Permira and Warburg Pincus have been on this journey with us for years. They first invested in Clearwater Analytics in 2020, know our business deeply, and continue to back our team, strategy, and long-term vision. Our current board includes Andy Young from Permira and Cary Davis from Warburg Pincus. c. Francisco Partners is joining as a new investor. They bring strong technology and software expertise, supporting our continued investment in innovation—including Gen AI—and our vision to build a front-to-back platform. Temasek adds long-term strategic investment experience and a strong presence in APAC, which is a priority growth market for CWAN. 3. What does this mean for employees? a. What happens to my vested RSUs / PSUs and Options? i. RSUs and PSUs granted that are vested when the transaction closes will be settled shortly thereafter for the same $24.55 per share received by stockholders. ii. All options will also be settled shortly after closing for the difference between the strike price and $24.55. If the strike price is at or above $24.55, then those options will be cancelled for no payment at closing. b. What happens to my unvested RSUs and PSUs that were issued prior to the announcement? i. All RSUs that remain unvested at the time of closing will continue to vest on the schedule that has been outlined in your grant letter, ii. All PSUs that remain unvested at the time of closing will continue to vest on the schedule that has been outlined in the grant letter but solely based on the time-based conditions in your grant letter. Given our recent financial performance, the performance condition will be deemed achieved at the maximum 110% level. iii. As your awards vest after closing, instead of receiving shares you will receive cash equal to $24.55 per share at the next payroll date following the vesting. Normal taxes will be withheld in the regular course. c. What happens to vesting that is scheduled to occur prior to the closing of the transaction? i. As the transaction is currently expected to close in the first half of 2026, awards that vest prior to close will vest normally as per the terms set forth in the grant letter. d. What about the ESPP (Employee Stock Purchase Plan)? i. If the trans